BOBULSKY SUSAN 4
4 · Adaptive Biotechnologies Corp · Filed Oct 10, 2024
Insider Transaction Report
Form 4
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-10-08−5,000→ 0 totalExercise: $1.98Exp: 2024-10-13→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-10-08$1.98/sh+5,000$9,900→ 253,290 total
Footnotes (1)
- [F1]The options are fully exercisable.